Yin Dou

Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Decoding Undesirable Inflammatory Responses of Nucleic Acid-Delivering Lipid Nanoparticles.

Decoding Undesirable Inflammatory Responses of Nucleic Acid-Delivering Lipid Nanoparticles.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 19, 2026

Inflammation-triggered self-immolative conjugates enable oral peptide delivery by overcoming gastrointestinal barriers.

Inflammation-triggered self-immolative conjugates enable oral peptide delivery by overcoming gastrointestinal barriers.

Journal: Science advances

Published: January 14, 2026

Therapeutic hypothermia reprograms nanocarrier protein corona via apolipoprotein C1 enrichment for precision cardiovascular therapy.

Therapeutic hypothermia reprograms nanocarrier protein corona via apolipoprotein C1 enrichment for precision cardiovascular therapy.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 13, 2025

Orally deliverable biomimetic nucleic acid therapies for targeted treatment of atherosclerosis.

Orally deliverable biomimetic nucleic acid therapies for targeted treatment of atherosclerosis.

Journal: Acta pharmaceutica Sinica. B

Published: October 08, 2024

Genome editing mRNA nanotherapies inhibit cervical cancer progression and regulate the immunosuppressive microenvironment for adoptive T-cell therapy.

Genome editing mRNA nanotherapies inhibit cervical cancer progression and regulate the immunosuppressive microenvironment for adoptive T-cell therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: December 26, 2022

Pathologically triggered in situ aggregation of nanoparticles for inflammation-targeting amplification and therapeutic potentiation.

Pathologically triggered in situ aggregation of nanoparticles for inflammation-targeting amplification and therapeutic potentiation.

Journal: Acta pharmaceutica Sinica. B

Published: February 03, 2022

Combination inhibition of triple-negative breast cancer cell growth with CD36 siRNA-loaded DNA nanoprism and genistein.

Combination inhibition of triple-negative breast cancer cell growth with CD36 siRNA-loaded DNA nanoprism and genistein.

Journal: Nanotechnology

Published: February 13, 2021

Luminescence Imaging of Acute Liver Injury by Biodegradable and Biocompatible Nanoprobes.

Luminescence Imaging of Acute Liver Injury by Biodegradable and Biocompatible Nanoprobes.

Journal: ACS nano

Published: August 14, 2020

Bioresponsive drug delivery systems for the treatment of inflammatory diseases.

Bioresponsive drug delivery systems for the treatment of inflammatory diseases.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: June 10, 2020

Cyclodextrin-Derived Intrinsically Bioactive Nanoparticles for Treatment of Acute and Chronic Inflammatory Diseases.

Cyclodextrin-Derived Intrinsically Bioactive Nanoparticles for Treatment of Acute and Chronic Inflammatory Diseases.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: July 18, 2019

A Multifunctional Nanotherapy for Targeted Treatment of Colon Cancer by Simultaneously Regulating Tumor Microenvironment.

A Multifunctional Nanotherapy for Targeted Treatment of Colon Cancer by Simultaneously Regulating Tumor Microenvironment.

Journal: Theranostics

Published: February 24, 2019

Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity.

Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity.

Journal: ACS nano

Published: August 17, 2018

Showing 1-12 of 24

Last Updated: 09/26/2026